LumiMeds Review 2026

LumiMeds advertises compounded semaglutide from $89 per month and compounded tirzepatide from $125 per month, with no separate membership. The public pricing FAQ now says price may increase as the prescribed dose is titrated. Monthly, 3-, 6-, and 12-month options are advertised, but every plan total and dose tier is not public. These figures are lower bounds, not reliable 12-month averages. The fixed-term membership terms require payment of the full commitment once the term begins.

Every prescription is described as clinician-reviewed and filled by a state-licensed compounding pharmacy. That is a meaningful safeguard, but it is not the same as FDA approval. FDA also issued LumiMeds a warning letter after finding marketing statements that misleadingly implied its compounded products were the same as approved drugs. Current product pages now state that compounded medications are not FDA-approved.

The process starts with a short online assessment, followed by review from a licensed provider. No office visit is advertised, and users receive a refund if the clinician finds them ineligible. The public flow is simple, although exact timing from intake to clinical decision is not guaranteed.

The main weight-loss choices are compounded semaglutide and compounded tirzepatide in multi-dose vials with syringes. Both are advertised as once-weekly injections with provider-guided titration. The specific pharmacy and final formulation can depend on the prescription and fulfillment network.

Temperature-controlled delivery is included in the advertised plan cost. LumiMeds asks customers to report shipping errors or damage within 48 hours, and replacement decisions are reviewed case by case. Public pages do not promise one nationwide delivery window.

LumiMeds lists phone support and extended service hours, while product pages describe ongoing provider messaging and monthly check-ins. The site does not publish a guaranteed response time, so urgent questions should be directed to the treating clinician or appropriate emergency services rather than relying on the platform.

The site explains the basic treatment flow, starting prices, medication form, and major inclusions in plain language. Its biggest usability weakness is cost comparison: visitors cannot see a complete table of every plan total and commitment without moving further into the purchase flow.